NCT02187198View on ClinicalTrials.gov

Buprenorphine Treatment for Opioid Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 1, 2022

Study Completion Date

January 1, 2023

Conditions
Opioid Dependence
Interventions
DRUG

Buprenorphine

Trial Locations (1)

06516

VA Connecticut Healthcare System - West Haven Campus, West Haven

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Yale University

OTHER

NCT02187198 - Buprenorphine Treatment for Opioid Dependence | Biotech Hunter | Biotech Hunter